Robert J. Pelham

6.3k total citations · 2 hit papers
28 papers, 4.7k citations indexed

About

Robert J. Pelham is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Robert J. Pelham has authored 28 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Robert J. Pelham's work include Cellular Mechanics and Interactions (6 papers), Cancer Genomics and Diagnostics (6 papers) and Prostate Cancer Treatment and Research (5 papers). Robert J. Pelham is often cited by papers focused on Cellular Mechanics and Interactions (6 papers), Cancer Genomics and Diagnostics (6 papers) and Prostate Cancer Treatment and Research (5 papers). Robert J. Pelham collaborates with scholars based in United States, United Kingdom and Spain. Robert J. Pelham's co-authors include Yu‐li Wang, Fred Chang, Lubomir B. Smilenov, Gregg G. Gundersen, Eugene E. Marcantonio, Alexei Mikhailov, Tara Maddala, Eric A. Klein, Sara M. Falzarano and Steven Shak and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert J. Pelham

27 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell locomotion and focal adhesions are regulated by substrate flexibility

1997 2.4k citations Robert J. Pelham, Yu‐li Wang Proceedings of the National Academy of Sciences profile →
A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

2014 447 citations Eric A. Klein, Matthew R. Cooperberg et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert J. Pelham United States	16	2.9k	1.8k	1.3k	617	616	28	4.7k
Nastaran Zahir United States	7	3.5k 1.2×	2.5k 1.4×	1.2k 1.0×	859 1.4×	192 0.3×	12	5.4k
Claudia Tanja Mierke Germany	38	2.0k 0.7×	1.4k 0.8×	1.0k 0.8×	577 0.9×	182 0.3×	85	4.0k
Emad Moeendarbary United Kingdom	31	2.3k 0.8×	1.3k 0.7×	1.4k 1.1×	251 0.4×	266 0.4×	73	4.5k
Alberto Elósegui-Artola Spain	26	3.3k 1.1×	1.7k 1.0×	1.5k 1.2×	603 1.0×	144 0.2×	37	5.1k
Michael L. Smith United States	30	1.3k 0.4×	903 0.5×	785 0.6×	905 1.5×	290 0.5×	55	3.4k
Matthew J. Paszek United States	20	3.8k 1.3×	2.1k 1.2×	2.1k 1.7×	989 1.6×	214 0.3×	46	6.3k
Sanjay Kumar United States	46	5.0k 1.7×	3.7k 2.1×	2.2k 1.7×	615 1.0×	310 0.5×	139	8.4k
Janna K. Mouw United States	18	1.8k 0.6×	1.2k 0.7×	1.8k 1.4×	578 0.9×	341 0.6×	27	5.0k
Polina Goichberg Israel	24	1.7k 0.6×	941 0.5×	1.4k 1.1×	480 0.8×	192 0.3×	38	4.6k
Bernhard Wehrle‐Haller Switzerland	38	3.0k 1.0×	797 0.5×	2.3k 1.8×	1.8k 2.9×	228 0.4×	85	5.7k

Countries citing papers authored by Robert J. Pelham

Since Specialization

Citations

This map shows the geographic impact of Robert J. Pelham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Pelham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Pelham more than expected).

Fields of papers citing papers by Robert J. Pelham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Pelham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Pelham. The network helps show where Robert J. Pelham may publish in the future.

Co-authorship network of co-authors of Robert J. Pelham

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Pelham. A scholar is included among the top collaborators of Robert J. Pelham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Pelham. Robert J. Pelham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balasooriya, Eranga R., Haley Ellis, Yuanli Zhen, et al.. (2024). The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical Cancer Research. 30(10). 2181–2192. 6 indexed citations

Ciardiello, Fortunato, Yung‐Jue Bang, Andrés Cervantes, et al.. (2023). Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first‐line platinum‐based chemotherapy: Phase 2 study results. Cancer Medicine. 12(12). 13145–13154. 6 indexed citations

Stradella, Agostina, Melissa L. Johnson, Sanjay Goel, et al.. (2020). 530MO Clinical benefit in biomarker-positive patients (pts) with locally advanced or metastatic solid tumours treated with the PARP1/2 inhibitor pamiparib in combination with low-dose (LD) temozolomide (TMZ). Annals of Oncology. 31. S465–S466. 1 indexed citations

Stradella, Agostina, Melissa L. Johnson, Sanjay Goel, et al.. (2019). Updated results of the PARP1/2 inhibitor pamiparib in combination with low-dose (ld) temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumours. Annals of Oncology. 30. v166–v167. 1 indexed citations

Ludwig, Heinz, Andrew Spencer, Tibor Kovacsovics, et al.. (2017). Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study. Blood. 130. 3125–3125. 4 indexed citations

Pelham, Robert J., Xuguang Hu, Philippe Moreau, et al.. (2017). Genomic Predictors of Progression-Free Survival Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Carfilzomib and Dexamethasone or Bortezomib and Dexamethasone in the Phase 3 Endeavor Trial. Blood. 130(Suppl_1). 839–839. 3 indexed citations

Barasch, Nicholas, Xue Gong, Kevin Kwei, et al.. (2017). Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma. PLoS ONE. 12(2). e0171265–e0171265. 47 indexed citations

Jamal‐Hanjani, Mariam, Gareth A. Wilson, Stuart Horswell, et al.. (2016). Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. Annals of Oncology. 27(5). 862–867. 133 indexed citations

Kırkızlar, Eser, Bernhard Zimmermann, T Constantin, et al.. (2015). Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology. Translational Oncology. 8(5). 407–416. 45 indexed citations

10.

Klein, Eric A., Matthew R. Cooperberg, Cristina Magi‐Galluzzi, et al.. (2014). A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling. European Urology. 66(3). 550–560. 447 indexed citations breakdown →

11.

Kwei, Kevin, Joffre Baker, & Robert J. Pelham. (2012). Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection. PLoS ONE. 7(9). e46518–e46518. 40 indexed citations

12.

Sinicropi, Dominick, Kunbin Qu, François Collin, et al.. (2012). Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue. PLoS ONE. 7(7). e40092–e40092. 59 indexed citations

13.

Klein, Eric A., Michael Crager, Cristina Magi‐Galluzzi, et al.. (2012). Identification of prostate cancer-expressed microRNAs associated with clinical recurrence (cR) and prostate cancer-specific survival (PCSS) following radical prostatectomy (RP).. Journal of Clinical Oncology. 30(5_suppl). 21–21. 1 indexed citations

14.

Pelham, Robert J. & Fred Chang. (2002). Actin dynamics in the contractile ring during cytokinesis in fission yeast. Nature. 419(6902). 82–86. 264 indexed citations

15.

Pelham, Robert J. & Fred Chang. (2001). Role of actin polymerization and actin cables in actin-patch movement in Schizosaccharomyces pombe. Nature Cell Biology. 3(3). 235–244. 145 indexed citations

16.

Pelham, Robert J. & Yu‐li Wang. (1999). High Resolution Detection of Mechanical Forces Exerted by Locomoting Fibroblasts on the Substrate. Molecular Biology of the Cell. 10(4). 935–945. 207 indexed citations

17.

Mikhailov, Alexei, et al.. (1999). Cytoskeletal Dynamics. Science. 283(5410). 1977l–1977.

18.

Wang, Yu‐li & Robert J. Pelham. (1998). [39] Preparation of a flexible, porous polyacrylamide substrate for mechanical studies of cultured cells. Methods in enzymology on CD-ROM/Methods in enzymology. 298. 489–496. 311 indexed citations

19.

Pelham, Robert J., et al.. (1998). Cell Locomotion and Focal Adhesions Are Regulated by the Mechanical Properties of the Substrate. Biological Bulletin. 194(3). 348–350. 135 indexed citations

20.

Pelham, Robert J. & Yu‐li Wang. (1997). Cell locomotion and focal adhesions are regulated by substrate flexibility. Proceedings of the National Academy of Sciences. 94(25). 13661–13665. 2417 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact